Ligand validation:6X9I

EDO: 1,2-ETHANEDIOL

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6X9I_EDO_A_1704	38%	80%	0.123	0.824	0.49	0.35	-	-	0	0	100%	1
6X9I_EDO_A_1707	30%	84%	0.186	0.847	0.49	0.28	-	-	0	0	100%	1
6X9I_EDO_A_1706	29%	82%	0.16	0.816	0.47	0.33	-	-	0	0	100%	1
6X9I_EDO_A_1708	9%	82%	0.367	0.866	0.46	0.34	-	-	0	0	100%	1
7SFC_EDO_A_1706	82%	85%	0.081	0.935	0.58	0.18	-	-	0	0	100%	1
3SWR_EDO_A_111	73%	83%	0.132	0.959	0.39	0.39	-	-	0	0	100%	1
7SFE_EDO_A_1701	60%	82%	0.099	0.883	0.45	0.35	-	-	0	0	100%	1
4KXW_EDO_A_1003	100%	73%	0.033	0.993	0.64	0.4	-	-	0	0	100%	1
8JK3_EDO_A_304	100%	81%	0.033	0.992	0.22	0.58	-	-	0	0	100%	1
7CJO_EDO_B_1210	100%	83%	0.038	0.99	0.47	0.32	-	-	0	0	100%	1
4O78_EDO_A_202	100%	86%	0.043	0.992	0.4	0.33	-	-	0	0	100%	1
6QRS_EDO_A_401	100%	83%	0.045	0.991	0.47	0.31	-	-	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.